Orrick Advises TCV on its Investment in SuperVista

July.19.2016

In one of Germany’s largest VC financings of 2016, Technology Crossover Ventures (TCV) has invested in SuperVista AG, a family-run eyewear company headquartered in Wildau, Germany.

TCV has invested in SuperVista by way of a combination of subscription of newly issued shares in SuperVista and a purchase of shares from existing shareholders. The investment was a complex transaction that involved many shareholders and subsidiaries of SuperVista across various jurisdictions.

TCV is a leading provider of capital to growth-stage private and public companies in the technology sector, headquartered in Palo Alto, California. TCV’s investments include Altiris, C|NET, ExactTarget, Expedia and Facebook.

SuperVista, a leading multi-channel provider of prescription eyewear in Germany, intends to use the funding to expand its executive team and enter new markets beyond Germany, Austria, the U.K. and Spain.

A cross-border team consisting of lawyers from Orrick’s Munich, Dusseldorf and London offices advised on the transaction. The team was led by partner Dr. Thomas Schmid (Corporate/M&A, Munich) and included partners Dr. Fabian von Samson-Himmelstjerna (Corporate/M&A, Munich), Dr. Stefan Schultes-Schnitzlein (Tax, Dusseldorf), Dr. Christian Schröder (IP/IT, Dusseldorf), Dr. André Zimmermann (Employment, Dusseldorf), Dr. Till Steinvorth (Antitrust, Dusseldorf), Dr. Timo Holzborn (Corporate, Munich), and associates Michael Rebholz (Corporate/M&A, Munich), Louisa Kallhoff (Employment, Dusseldorf), Sophie Ratzke (IP/IT, Dusseldorf), Clarissa Otto (IP/IT, Corporate, Dusseldorf), Christopher Mayston (Corporate, Munich) and Katrina Murphy (General Corporate, London).